Sunburn Clinical Trial
Official title:
Hats on Head Start: A Survey of Sun Protection Behaviors in Head Start and Other Early Childhood Education Programs
The proposed study will assess the current sun safety policies and practices in programs for
young children and to determine the willingness of stakeholders to incorporate more
protective measures.
The primary hypothesis is that children in Head Start programs, daycare programs, elementary
schools, or summer camps are exposed to significant UV radiation throughout the day, and are
not adequately protected with sunscreen, hats, or sun-protective clothing. The secondary
hypothesis is that these programs value sun safety as an important health behavior, but
probably do not have the funding avilable to make it a priority.
The study aims are:
1. To assess current exposure to sun and UV in programs of children participating in an
early childhood educational program.
2. To assess current policies regarding sun protection and sunscreen use in programs for
early childhood education.
3. To assess the current attitudes towards sun safety among caregivers and teachers in
programs for early childhood education.
4. To explore association of sun protective behaviors with risk factors such as
socioeconomic status, per student classroom budget, program setting (i.e. urban,
suburban, or rural), race/ethnicity, size of school program, school budget for supplies,
and ages of children enrolled in program.
The sample of stakeholders, who will be surveyed, is consistent with samples used in our
prior research. A sample size of 250 phone interviews will be adequate to show trends in sun
safety policies among early education programs. Power analysis is based on the use of sun
protection, our primary outcome. Our preliminary data show that 15% of schools almost always
or always schedule outdoor activities to avoid times when the sun was at peak intensity. The
sample size required to sensitively detect a 20% difference in using sun protection between
those that comply with recommendations and those that do not is 250 respondents assuming an
alpha < 0.05 and power >= 0.8 in a two-tailed test on a two-group sample. This sample size
will adequately power the study for detecting 30% difference in sun protection use between
the two groups.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00206882 -
The Sun Protection Effect and Efficacy in Treatment of Sunburn Using Topical Corticosteroids.
|
N/A | |
Completed |
NCT05767008 -
Water Immersion Studies of a Long-wear Sunscreen to Improve Protection Against Ultraviolet Radiation
|
N/A | |
Completed |
NCT00441051 -
Efficacy and Safety of Diclofenac Sodium (0.1%) Gel in Patients With UV Induced Painful Sunburn
|
Phase 3 | |
Completed |
NCT01873430 -
The Sun Protective Effect of Melatonin
|
Phase 1 | |
Completed |
NCT00326274 -
Clinical Safety Trial of Long-Term Intermittent Use of Helioblock® SX Cream
|
Phase 3 | |
Terminated |
NCT03332524 -
Clinical Trial of the Safety and Efficacy of SP160412 in the Temporary Relief of Mild to Moderate Sunburn
|
Phase 2 | |
Completed |
NCT03752736 -
Sun Safety Skills for Elementary School Students
|
N/A | |
Completed |
NCT05260359 -
Dermal Irritation, Sensitization and Cumulative Irritation Potential of 6% Bemotrizinol
|
Phase 2 | |
Completed |
NCT01021787 -
Dermal Penetration of the Titanium Dioxide in Anthelios SX SPF40 Cream
|
Phase 4 | |
Completed |
NCT03607578 -
Test of Interventions to Prevent Skin Cancer Among Danes on Vacation in High UV Index Sunny Destinations
|
N/A | |
Completed |
NCT03489356 -
Project Options - The ABC Method
|
N/A | |
Enrolling by invitation |
NCT03007589 -
Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics
|
N/A | |
Not yet recruiting |
NCT01085851 -
Non-inferiority Clinical Trial of Dexchlorpheniramine (Cream Versus Lotion) in the Relief of Sunburn Related Symptoms
|
Phase 3 | |
Not yet recruiting |
NCT01237925 -
Non-inferiority Clinical Trial of Dexchlorpheniramine (Cream Versus Gel) in the Relief of Sunburn Related Symptoms
|
Phase 3 |